Robust affinity materials for applications in proteomics and diagnostics
PEPMIP represents a joint European effort involving eleven partners aimed at the development of the next generation of dedicated separation materials, designed to recognize peptides and proteins, and the implementation of these ma...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BioCapture
Smart capture phases for proteomics glycomics and biomarker...
3M€
Cerrado
HIPAD
High Density Peptide MicroArrays and high throughput label...
6M€
Cerrado
CTQ2008-02429
DISEÑO MOLECULAR DE RECEPTORES DE AFINIDAD Y CATALITICOS BAS...
420K€
Cerrado
MULTIPOC
Highly Multiplexed Affinity Proteomics for Point of Care Dia...
2M€
Cerrado
RYC2019-027199-I
Peptide-based chemical tools for biological research: from s...
309K€
Cerrado
UNPO15-CE-3339
Adquisición de infraestructura científica para el Servicio d...
165K€
Cerrado
Información proyecto PEPMIP
Líder del proyecto
MALMO UNIVERSITET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
3M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
PEPMIP represents a joint European effort involving eleven partners aimed at the development of the next generation of dedicated separation materials, designed to recognize peptides and proteins, and the implementation of these materials in new high performance methods for peptide and protein analysis. Artificial receptors will be developed by various Molecular Imprinting techniques. This will be supplemented by a new class of generic peptide and protein fractionation tools that will be integrated in new formats to produce new protein/peptide separation and detection solutions. The research results will lead to technological advances having a major impact on 1) health care since it will profit from methods involving PEPMIPs for earlier, more reliable diagnosis of diseases, 2) drug discovery allowing a faster target or biomarker identification; and 3) biochemistry research laboratories in resulting in improved protein fractionation tools for revealing low abundant post translational modifications. The training will focus on 10 early stage researchers (ESRs) who, within four work packages, will develop a well-balanced spectrum of scientific, business and entrepreneurial skills that will be particularly attractive to European industry when the ESRs eventually leave PEPMIP.